Healius Limited (ASX:HLS) has disclosed the late lodgement of an Appendix 3Y Change of Director's Interest Notice for director Bruce Robinson, following an on-market purchase of 109,890 fully paid ordinary shares at an average price of $0.460 per share on 28 October 2026, held indirectly through his superannuation fund.

Key Points

  • Director Bruce Robinson acquired 109,890 fully paid ordinary shares on 28 October 2026 at an average price of $0.460 per share via an on-market trade.
  • The shares are held indirectly through the Bruce Gregory Robinson & Alice Ruth Killen Superannuation Fund, of which Robinson is a member and beneficiary.
  • The Appendix 3Y was not lodged within the five-business-day timeframe required under ASX Listing Rule 3.19A.2 due to an administrative oversight by the director.
  • ASX directed the company under Listing Rule 18.8 to provide an explanation, following consultation with the company.
  • Healius said it will provide refresher training to all directors regarding notification obligations and securities trading arrangements.

Details of the Share Acquisition by Bruce Robinson

According to the filing, Bruce Robinson held no securities prior to the transaction. Following the on-market purchase of 109,890 fully paid ordinary shares on 28 October 2026, his indirect holding stands at 109,890 fully paid ordinary shares. The shares are registered through the Bruce Gregory Robinson & Alice Ruth Killen Superannuation Fund. The filing confirms the interests were not traded during a closed period requiring prior written clearance. The previous director's interest notice for Robinson was dated 2 February 2026. No changes to director interests in contracts were disclosed.

Reason for Late Lodgement and ASX Direction

Healius disclosed that the Appendix 3Y was lodged outside the required five-business-day timeframe under ASX Listing Rule 3.19A.2 as a result of an administrative oversight by the director, who did not notify the company of the transaction within the required period. The company stated it became aware of the transaction on 20 November 2026 and lodged the Appendix 3Y promptly thereafter. Following consultation with ASX, the exchange directed Healius under Listing Rule 18.8 to provide details of the late lodgement, the company's existing compliance arrangements, and any additional steps being taken.

Company Disclosure Arrangements and Remedial Steps

Healius outlined its existing compliance arrangements, which include a Board-approved Policy on Trading in Healius Securities, procedures requiring directors to promptly notify the Company Secretary of any change in notifiable interests, and periodic guidance to directors regarding their disclosure obligations. The filing states the company considers its existing arrangements appropriate. However, Healius said it will provide refresher training to all directors on their notification obligations and reinforce the importance of promptly supplying the Company Secretary with information necessary to meet ASX Listing Rule disclosure requirements. The filing was authorised by Managing Director and CEO.